Managing gastrointestinal side-effects and preventing treatment discontinuation with GLP-1 therapies GI symptoms are the most common adverse effects of GLP-1 therapies, with nausea, constipation, diarrhea, and vomiting occurring in around 40 % of patients [11,[30], [31], [32]]
Recovery begins , grafts begin to stabilize within the first 1014 days
The appeal is obvious: they're cheaper, no prescription is needed, and they're framed as doing the same job as expensive, prescription-only injections
For those new to peptide protocols , building this weekly habit from day one makes the entire dose schedule easier to follow
The critical unknowns include: Cardiovascular Safety: The glucagon component requires independent, long-term evaluation in populations with a high risk of heart disease
The New Phase of the GLP-1 Journey When GLP-1 injections first gained attention, the focus was on weight loss